cyclohexanol has been researched along with fluorodeoxyglucose f18 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thase, ME | 1 |
| De Gori, R; Driguez, H; Fincher, GB; Hrmova, M; Smith, BJ; Varghese, JN | 1 |
| Benson, BE; Dunn, RT; Ketter, TA; Kimbrell, TA; Little, JT; Luckenbaugh, DA; Post, RM; Willis, MW | 1 |
| Artiges, E; Bragulat, V; Frouin, V; Martinot, JL; Paillère-Martinot, ML; Poline, JB | 1 |
| Bieling, PJ; Kennedy, SH; Konarski, JZ; Lau, MA; Mayberg, HS; McIntyre, RS; Segal, ZV | 2 |
3 trial(s) available for cyclohexanol and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain Mapping; Bupropion; Case-Control Studies; Cerebral Cortex; Cross-Over Studies; Cyclohexanols; Demography; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial.
Topics: Adult; Brain; Cerebral Cortex; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Limbic System; Male; Middle Aged; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain; Cognitive Behavioral Therapy; Cyclohexanols; Depressive Disorder, Major; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Middle Aged; Positron-Emission Tomography; Venlafaxine Hydrochloride; Young Adult | 2009 |
3 other study(ies) available for cyclohexanol and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Neuroimaging profiles and the differential therapies of depression.
Topics: Antidepressive Agents; Brain; Cyclohexanols; Depressive Disorder; Fluorodeoxyglucose F18; Glucose; Humans; Psychotherapy; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Catalytic mechanisms and reaction intermediates along the hydrolytic pathway of a plant beta-D-glucan glucohydrolase.
Topics: Catalytic Domain; Crystallography, X-Ray; Cyclohexanols; Fluorodeoxyglucose F18; Glucose; Glucosidases; Hordeum; Hydrolysis; Inositol; Models, Chemical; Models, Molecular; Peptide Mapping; Quantum Theory | 2001 |
Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis.
Topics: Adult; Affect; Biogenic Monoamines; Brain Stem; Caudate Nucleus; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Female; Fluorodeoxyglucose F18; Fluoxetine; Gyrus Cinguli; Hippocampus; Humans; Hypothalamus; Magnetic Resonance Imaging; Male; Nucleus Accumbens; Positron-Emission Tomography; Psychomotor Disorders; Putamen; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Venlafaxine Hydrochloride | 2007 |